Cellectar Biosciences Inc. (CLRB)
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
Encompass Health Corporation - Encompass Health announces date of 2025 fourth quarter earnings call
Revvity - Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models
Encompass Health announces date of 2025 fourth quarter earnings call